Centro de Investigaciones Medicas y Desarrollo LC

Buenos Aires, Buenos Aires F.D. 1113

0 studies enrolling now · 3 studies all time

What they study most

Advanced or Metastatic Breast Cancer, Breast Cancer, Ovarian Cancer, Small Cell Lung Cancer, Urothelial Carcinoma

Studies at this site

• Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2 — Running, not enrolling
• PF-07104091 as a Single Agent and in Combination Therapy — Running, not enrolling
• A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment — Running, not enrolling